RNA, U6 small nuclear 1055, pseudogene (RNU6-1055P)

RNU6-1055P is a processed pseudogene of the U6 small nuclear RNA gene. U6 snRNA is a key component of the spliceosomal machinery responsible for intron excision from pre-mRNA in the nucleus[1][3]. However, pseudogenes like RNU6-1055P are noncoding genomic fragments generated by retrotransposition, typically via LINE-1 (L1) activity[4]. These pseudogenes are not transcribed into functional RNA, lack protein-coding capacity, and do not have established biological roles or disease links. Pseudogenes such as RNU6-1055P are often used as markers for retrotransposon activity in genome evolution studies but are not considered molecular targets for therapy or pharmacology[4][5]. The parent gene, U6 snRNA, is evolutionarily conserved and crucial for spliceosome catalysis, but pseudogenes derived from U6, such as RNU6-1055P, are simply genomic remnants without biological function or clinical significance[1][3][4]. There is no evidence of direct involvement of RNU6-1055P in disease, signaling, or pharmacology. The entry is correctly named as a pseudogene, but if intended as a drug target or biomarker, the entity is incorrect—pseudogenes like this are not valid therapeutic targets.

Other names

RNU6-1055PU6 snRNA pseudogene 1055RNA, U6 snRNA pseudogene 1055